REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885 | -68.1% | 77,200 | -10.4% | 0.00% | -75.0% |
| Q1 2023 | $2,775 | -98.2% | 86,155 | +676.2% | 0.00% | – |
| Q2 2022 | $153,000 | -52.6% | 11,099 | -33.1% | 0.00% | – |
| Q1 2022 | $323,000 | -20.8% | 16,583 | -33.8% | 0.00% | – |
| Q4 2021 | $408,000 | +2300.0% | 25,048 | +4131.1% | 0.00% | – |
| Q2 2021 | $17,000 | -94.7% | 592 | -94.8% | 0.00% | – |
| Q1 2021 | $320,000 | -29.8% | 11,456 | -28.9% | 0.00% | -100.0% |
| Q4 2020 | $456,000 | – | 16,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |